Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Rang in aandelen #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Aandeelprijs
$0.117
Laatst gesynchroniseerd: 2025-04-04
Marktkapitalisatie
$2.45M
Verandering (1 dag)
-13.59%
Verandering (1 jaar)
0.00%
Land
US
Handel Carmell Therapeutics Corporation (CTCX)

Categorie

Koersgeschiedenis voor Carmell Therapeutics Corporation (CTCX)
Hoogste slotkoers: $0.13 op 2025-04-01

Laagste slotkoers: $9.69 op 2021-09-01
Koersgeschiedenis van Carmell Therapeutics Corporation van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2025 -52.71%
2024 -92.46%
2023 -63.87%
2022 1.86%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE